Bachem Holding AG

Swiss Stock Exchange BANB.SW

Bachem Holding AG Price to Earnings Ratio (P/E) on January 14, 2025: 34.43

Bachem Holding AG Price to Earnings Ratio (P/E) is 34.43 on January 14, 2025, a -12.40% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Bachem Holding AG 52-week high Price to Earnings Ratio (P/E) is 56.63 on May 16, 2024, which is 64.48% above the current Price to Earnings Ratio (P/E).
Bachem Holding AG 52-week low Price to Earnings Ratio (P/E) is 34.32 on January 13, 2025, which is -0.31% below the current Price to Earnings Ratio (P/E).
Bachem Holding AG average Price to Earnings Ratio (P/E) for the last 52 weeks is 47.28.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Swiss Stock Exchange: BANB.SW

Bachem Holding AG

CEO	Mr. Thomas Meier
IPO Date	July 17, 1998
Location	Switzerland
Headquarters	Hauptstrasse 144
Employees	2,009
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Key trends

Past 5 years